ACM
INBS icon

ADAR1 Capital Management’s Intelligent Bio Solutions INBS Stock Holding History

ADAR1 Capital Management’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42,643
Closed -$435K – 280
2025
Q3 		$435K Buy
+42,643
New +$687K 0.04% 145
2024
Q4 		– Sell
-539
Closed -$9.32K – 256
2024
Q3 		$9.32K Sell
539
-10,286
-95% -$160K ﹤0.01% 256
2024
Q2 		$208K Hold
10,825
– – 0.04% 141
2024
Q1 		$457K Buy
+10,825
New +$448K 0.1% 90

Other funds holding INBS

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $322M AUM 16.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.45B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ADAR1 Capital Management's INBS Position: Q4 2025 in Review

ADAR1 Capital Management sold out of Intelligent Bio Solutions (INBS) in Q4 2025, closing a stake of 42,643 shares — an estimated $435K sold.

ADAR1 Capital Management first reported a position in INBS in Q1 2024 and held it in 4 quarters. The position peaked at $457K in Q1 2024. 7 funds tracked by Wall St. Rank hold INBS as of Q4 2025.

  • ADAR1 Capital Management reported no remaining Intelligent Bio Solutions position as of Q4 2025 after selling out during the quarter.
  • ADAR1 Capital Management sold 42,643 Intelligent Bio Solutions shares in Q4 2025, an estimated $435K.
  • ADAR1 Capital Management first reported a position in Intelligent Bio Solutions in Q1 2024 and held it in 4 quarters.
  • ADAR1 Capital Management's Intelligent Bio Solutions position peaked at $457K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q4 2025.

Based on ADAR1 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.